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ABSTRACT
Purpose: Senegal is endemic for trachoma, an infectious and potentially blinding eye disease. To
complete the country’s district-level baseline map of trachoma, we conducted population-based
surveys in 17 health districts that were suspected-endemic but had yet to be surveyed.
Methods: We randomly selected 30 clusters (villages) per district and 30 households per village,
and estimated the district-level prevalences of trachomatous inflammation—follicular (TF) in
children aged 1–9 years, and trichiasis in persons aged ≥15 years. Data on household-level
water, sanitation, and hygiene variables were also collected. Global Trachoma Mapping Project
methods were followed in training, fieldwork, and data handling.
Results: 25,704 children aged 1–9 years and 30,345 adults aged 15 years and above were
examined. In children aged 1–9 years, the prevalence of TF was <5% in all 17 districts, with the
exception of Saint-Louis (5.1%, 95% CI 3.2–7.5). Trichiasis prevalence in participants aged 15 years
and above ranged by district from 0%–1.1% (95% CI 0.7–1.5), with 9 districts having trichiasis
prevalences above the elimination threshold of 0.2%. Trichiasis was seen to be significantly less
frequent in males than in females (0.17% [95% CI 0.12–0.24] versus 0.49% [95% CI 0.38–0.61],
p < 0.001). The prevalence of trichiasis rose steeply with age; 62% of cases were observed in
people aged 55 years or above.
Conclusions: Active trachoma is not a public health problem in 16 of the 17 surveyed districts, and
implementation of the full Surgery (S) – Antibiotics (A) – Facial cleanliness (F) – Environmental
improvement (E) strategy is not a programmatic priority. Increased provision of trichiasis surgery is
warranted in nine districts.
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Introduction
Trachoma is a chronic keratoconjunctivitis caused by
four serovars of Chlamydia trachomatis: A, B, Ba, and
C.1 Active trachoma, which is most commonly present
in young children, is characterized by chronic, folli-
cular conjunctivitis.2,3 Reinfection occurs in situations
where individual and group hygiene are poor, and
water and sanitation are lacking. Repeated infections
result in conjunctival scarring causing entropion (in-
turning of the eyelids) and trichiasis (eyelashes touch-
ing the eyeball). Corneal opacification resulting from
mechanical trauma from in-turned lashes, a dry ocular
surface and secondary infection, can ultimately lead to
blindness.1,4
Trachoma is responsible for a significant disease
burden in low-income countries. Current estimates
suggest that 200 million people are at risk of blindness
from trachoma, 1.9 million are already blind or severely
visually impaired, and 3.2 million have trichiasis.5,6
Efforts to eliminate trachoma as a public health pro-
blem, led by the World Health Organization (WHO)
Alliance for the Global Elimination of Trachoma by
2020 (GET2020), rely on a multifaceted approach: SAFE
(Surgery for trichiasis, Antibiotics to treat C. trachomatis
infection, Facial cleanliness and Environmental improve-
ment to reduce transmission). The thresholds for elim-
ination of trachoma as a public health problem are a
“trachomatous inflammation—follicular” (TF) preva-
lence <5% in children aged 1–9 years, and a “trachoma-
tous trichiasis” (TT) prevalence unknown to the health
system of <0.2% in adults aged 15 years and above.7 To
plan interventions at baseline, to assess their impact, and
to demonstrate achievement of elimination goals, reliable
prevalence data at the district level are required.
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In 1997, it was suggested that trachoma was the
second-leading cause of blindness in Senegal, with
nearly 25,000 people blind as a result of the disease8;
its control has therefore been a major focus of the
national blindness prevention policy. In line with
GET2020, Senegal has set the goal of eliminating tra-
choma as a public health problem by 2020.9 In 2000,
prevalence surveys were conducted in eight of the
country’s then-10 medical regions (i.e., Dakar,
Diourbel, Fatick, Kaolack, Louga, Saint Louis,
Tambacounda, and Thiès), to determine the prevalence
of trachoma. Kolda and Ziguinchor regions were not
included in that round of surveys, for security reasons.
These surveys were not designed to provide data at the
health district level.10
Four of the country’s medical regions were subdi-
vided in 2008, resulting in 14 regions overall and the
formation of new health districts.11 Between 2004 and
2013, district-level baseline surveys were completed in
37 districts (Table 1), using WHO-recommended
methods and sampling 30 clusters per district.12,13
These surveys were conducted incrementally as funds
became available, with priority given to zones that were
expected to be at greater risk of trachoma based on the
findings of the region-level prevalence surveys.
Based on these findings, and in line with WHO
guidance then in effect,13 antibiotic mass drug admin-
istration (MDA) was progressively introduced from
2005–2014 in 17 of the 18 districts where baseline
district (or sub-district) TF prevalence was ≥10%
among children aged 1–9 years. The eighteenth district,
a highly populous and urbanized area with a seasonally
fluctuating population, was resurveyed in 2016 to better
target MDA requirements,14 and initiated MDA in
2017. Facial cleanliness and environmental improve-
ment measures have been implemented periodically in
certain districts, but have not been consistently docu-
mented. Surgery for trichiasis was initiated in 2006 and
has principally been conducted in regions that
required MDA.
In order to complete the country’s district-level
baseline map of trachoma and determine the need for
trachoma elimination interventions in those districts
suspected to be endemic but not yet mapped, in 2014,
we conducted surveys in 17 health districts in colla-
boration with the Global Trachoma Mapping Project
(GTMP).15
Methods
Ethics statement
The surveys were led by the Ministry of Health and
Social Work (MSAS)’s National Eye Health
Promotion Program (PNPSO). Ethical clearance
was obtained from the MSAS’s Planning of
Research and Statistics Directorate (Protocole
SEN13/66 - Nº044 MSAS/DPRS/DR, 21 January
2014), based on the review of the National Ethics
Committee for Health Research; and from the ethics
committee of the London School of Hygiene &
Tropical Medicine (reference 6319).
In each village, the survey team paid a courtesy visit to
the village head to explain the purpose of the survey.
General information about trachoma was given prior to
starting surveys. Verbal informed consent was given by the
head of the household for children aged <15 years, and by
participants themselves when aged 15 years or above.
Consent for trachoma examination and interviews was
documented by the field team on the electronic data form
in theGTMP-LINKS application.15 Children found to have
Table 1. District-level estimates of baseline trachoma preva-
lence in Senegal generated prior to 2014.
Region District
Prevalence of
trachomatous
inflammation–
follicular in
children aged
1–9 years, %
Prevalence of
trichiasis in those
aged ≥15 years, %
(women only,
unless noted)
Year
of
survey
Diourbel Diourbel 14.9 4.7 2010
Mbacké 13.4 1.6 2010
Touba 15.1 3.1 2011
Fatick Dioffior 1.4 1.4 2011
Fatick 1.3 2.0 2011
Foundiougne 2.4 1.1 2013
Gossas 11.7 3.3 2011
Niakhar 4.4 1.7 2013
Passy 5.4 1.4 2013
Sokone 4.5 1.0 2011
Kaffrine Birkélane 13.9 1.4 2010
Kaffrine 13.9 1.4 2010
Koungheul 11.5 2.1 2010
Malem
Hodar
11.7 2.9 2011
Kaolack Guingineo 7.6 2.9 2011
Kaolack 3.6 1.6 2011
Ndoffane 12.9 2.5 2011
Nioro 7.4 1.6 2010
Louga Coki 9.8 2.3 2012
Dahra 6.3 0.8 2011
Darou
Mousty
8.8 1.6 2008
Keur Momar
Sarr
2.7 0.8 2012
Linguère 2.8 0.3 2009
Louga 5.1 1.6 2010
Sakal 9.1 1.6 2010
Thiès Joal 7.8 2.0 2004
Khombole 11.6 3.6 2004
Mbour 7.1 1.5 2005
Mékhé 23.6 4.5 2004
Popenguine 6.2 1.9 2005
Pout 4.8 2.1 2005
Thiadiaye 6.7 5.2 2005
Thiès 4.8 2.1 2004
Tivaouane 28.7 4.5 2004
Ziguinchor Bignona 2.3 1.5 (women & men) 2010
Diouloulou 2.9 1.1 (women & men) 2010
Thionk-Esyl 2.1 1.7 (women & men) 2010
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TF were given tetracycline 1% ointment to apply twice
daily for 6 weeks. Trichiasis cases were referred for surgery.
Evaluation units
Senegal is divided into 14 medical regions, which are
further divided into 76 health districts (Figure 1). The
17 health districts mapped in 2014 were drawn from
five medical regions. The two northern regions (Saint
Louis and Matam) are bordered by Mauritania, and the
three southern regions (Ziguinchor, Sédhiou, Kolda)
are bordered by Gambia to the north and by Guinea-
Bissau and/or Republic of Guinea to the south
(Figure 2). The north is characterized by a hot desert
climate, and the south by a tropical wet and dry
climate.
All districts in Saint Louis, Matam, Séhiou, and
Kolda were surveyed. In Ziguinchor Region, two
districts were surveyed; the region’s other three dis-
tricts completed their surveys in 2010 (Table 1).
The population of the districts surveyed ranged
from 50,944 to 303,659.
Figure 1. Map of Senegal, showing regions and districts, 2014.
Figure 2. Map of Senegal, showing the 17 districts mapped for trachoma in 2014.
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Survey design and sampling
Our work here consisted of a series of community-
based cross-sectional surveys designed to assess dis-
trict-level prevalence of TF in children aged 1–9 years,
and trichiasis in adults aged 15 years and above. This
involved examination of participants for clinical signs
of trachoma using the WHO simplified trachoma grad-
ing system,16 recording each of TT, TF, and trachoma-
tous inflammation-intense (TI) as absent or present;
the other signs of the simplified system (trachomatous
conjunctival scarring (TS) and corneal opacity (CO))
were not recorded.17 This was the first time that tra-
choma baseline surveys in Senegal consistently assessed
both females and males for trichiasis; most previous
surveys of trichiasis conducted in the country had
included women only. Inclusion of males as well as
females is in line with the WHO protocol,13 and is an
important methodological consideration as it avoids the
overestimation of prevalence in the overall population
resulting from examining females only.18
A two-stage cluster random sampled design with
probability proportional to size was used to select the
sample in each district, as recommended by WHO.13
Thirty clusters (villages) per district were randomly
selected in the first stage. The second-stage selection,
witnessed by the head of each selected village, took
place in the field. Thirty households per village were
randomly drawn from a list of households provided by
the village head.15 If the village had fewer than 30
households, the nearest village was also visited and
random selection performed to complete 30
households.
As outlined elsewhere,15 the sample size for the
survey was calculated to estimate with 95% confidence
an expected 10% TF prevalence in children aged
1–9 years, with absolute precision of 3% and a design
effect of 2.65. With inflation by a factor of 1.2 to allow
for non-response, this gave rise to a sample size of
1,222 children in selected households per district, with
the expectation that about 1,019 children would be
examined.
Training
Eight ophthalmic clinical officers (Technicien supérieur
opthalmologique or TSO) working in the Senegalese
health system (prospective trachoma graders), and five
people with information technology backgrounds (pro-
spective data recorders), underwent a 5-day training
program led by a GTMP-certified master grader15
(Boubacar Sarr) and a GTMP-certified grader trainer15
(Mactar Sissoko), who also provided field supervision
during the survey. Version 2 of the training system was
used.17 Prospective trachoma graders were trained on
examination using the WHO simplified grading system
and on standardized procedures for selection of
households.17 A practical test was conducted in a
non-survey cluster in Thiès district, with the help of
children attending three traditional Koranic schools
(daraas).
To participate in the survey, prospective trachoma
graders had to achieve a kappa score of at least 0.8 in
inter-grader agreement with the grader trainer, in iden-
tification of TF in children. Data recorders were trained
to conduct household interviews and to capture data
using Android smartphones (Motorola Atrix 2,
Motorola Inc., Schaumburg, IL), and the LINKS appli-
cation from the Task Force for Global Health, following
the GTMP protocol. After training, 4 trachoma graders
and 4 data recorders passed their respective tests and
were selected to conduct the survey.
Household survey
Each village has a Health Post Head Nurse (Infirmier
Chef de Poste) whose main responsibilities are to man-
age the health post (center) and to supervise all health-
related activities at village level. Health Post Head
Nurses were briefed about the surveys by the Health
District Head Doctor (Médecin-Chef de District) prior
to teams visiting the selected villages. They facilitated
contact with the village heads and assisted the survey
team in developing a calendar for visits, as well as
designating one village resident to serve as a guide.
There were four survey teams, each consisting of one
grader, one data recorder, one driver, and one guide.
Upon arrival in the village and after meeting with
the village head, consent was obtained from the house-
hold head of each selected household. Global position-
ing system (GPS) data were collected at each
household. All eligible participants were examined for
trachoma signs using a 2.5× magnifying binocular
loupe and a torch (flashlight) or sunlight. Household
interview questions included, inter alia, the source of
drinking water, time needed to fetch water, main
source of water for face washing, defecation habits,
and sanitation facilities. Some information was col-
lected by direct observation, as described elsewhere.15
Data management and analysis
Field data collection was performed using the LINKS
app on Android smartphones. Data forms were
uploaded each day using 256-bit SSL encryption to
the GTMP secure server, housed on the Amazon
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Elastic Compute Cloud.19 Prevalences were calculated
with gender- and age-adjustment using R 3.0.2 (The R
Foundation for Statistical Computing, Vienna, Austria)
and Structured Query Language, as described
elsewhere,15 using 2013 Senegal census data as the
reference population set.20 The district-level adjusted
prevalence was determined by mean of adjusted clus-
ter-level proportions of children with TF. The same
method was used to calculate the district-level adjusted
trichiasis prevalence, but with adjustment for both
gender and age in 5-year age groups. Confidence inter-
vals around prevalence estimates were calculated by
bootstrapping the cluster means over 10,000 iterations
and taking the 2.5th and 97.5th centiles of all ordered
results.
Prevalence was calculated for trichiasis, which can be
due to multiple causes,21 rather than for TT, because
the presence or absence of TS was not recorded in eyes
with trichiasis; consensus for recording TS was estab-
lished after these surveys were conducted.22
Risk factors associated with active trachoma were
investigated using STATA 14 (StataCorp, College
Station, TX). Variables were examined in univariate
analyses as well as through multiple regression. Risk
factor means were generated without sample weights,
and standard errors were adjusted for clustering using
Taylor linearization.
Results
Study population
Between March and October 2014, a total of 71,493
(25,704 children aged 1–9 years, 36,633 adults aged
15 years and above) individuals were enumerated and
63,716 (25,144 children aged 1–9 years, 30,345 adults
aged 15 years and above) were examined for trachoma
(response rate of 89.1%) in the 17 districts. Of the 7,777
people not examined, 98.7% were absent and 59.0%
were male aged 15 years and above. The mean age of
participants included in the study was 21.1 years
(sd = 19.8); 54.7% were female (Table 2).
Prevalence of TF and trichiasis, and risk factors
Table 3 summarizes the prevalence of TF and trichiasis
in each district. All districts had a TF prevalence below
5% with the exception of Saint-Louis (5.1%, 95% CI
3.2–7.5) (Figure 3). Among children aged 1–9 years
sampled, the proportion of males with TF was not
significantly higher than that of females (2.9% [375/
12,554] versus 2.6% [334/12,441], p = 0.17) (Figure 5).
The prevalence of trichiasis in individuals aged 15 years
and above ranged by district from 0% to 1.1% (95% CI
0.7–1.5) (Figure 4). We identified no cases of trichiasis
in three districts (Matam, Ranérou, Pété). Of the 203
cases identified in the other 11 districts, the proportion
of males with trichiasis was significantly lower than that
of females (0.3% [58/15,125] versus 0.7% [145/21,305],
p < 0.001). This difference between prevalence of tri-
chiasis in male and female adults remained significant
after adjusting both estimates for age (0.17% [95% CI
0.12–0.24] versus 0.49% [95% CI 0.38–0.61], p < 0.001).
The prevalence of trichiasis rose steeply with age; 62%
of cases were in people aged 55 years or above
(Figure 6).
Household-level access to improved water source
for face washing ranged by district from 16.6% to
87.0% (Table 2). “Improved” sources of water
included piped water into dwelling; piped water to
yard/plot; public tap or standpipe; tubewell or bore-
hole; protected dug well; protected spring; and
rainwater.17,23 Respondents from nearly half the
households (47.5%) reported using an unprotected
dug well as the main source of water for washing
faces. Household-level access to improved latrines
ranged by district from 7.3% to 93.1% (Table 2).
“Improved” sanitation included flush toilet; piped
sewer system; septic tank; flush/pour flush to pit
latrine; ventilated improved pit latrine (VIP); pit
latrine with slab; composting toilet; and flush/pour
flush to unknown place.17,23 67.0% of respondents
reported having a round trip to collect water of less
than 30 minutes (Table 2). It should be noted that
within a given household, responses about availabil-
ity and use of latrines could be provided by several
different respondents.
Univariate analysis identified water retrieval time
as the only risk factor among those investigated to
have a significant (p ≤ 0.05) relationship to TF in
children aged 1–9 years. Specifically, a round-trip of
less than 30 minutes to collect water for face wash-
ing was associated with lower odds of TF (OR 0.54,
95% CI 0.4–0.7, p < 0.001). No significant relation-
ship was observed between TF and self-reported
location of defecation by adults aged 15 years and
above (using latrines vs. no structure) (OR 1.11,
95% CI 0.8–1.5, p = 0.504), having an improved
latrine type in the household (OR 1.05, 95% CI
0.8–1.4, p = 0.723), or having an improved water
source for face washing (OR 1.27, 95% CI 0.98–
1.64, p = 0.065). Similarly, no significant relation-
ship was found between TF and having a functional
handwashing station nearby, specified as one with
soap and water within 15 meters (OR 1.67, 95% CI
0.96–2.89, p = 0.068).
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The relationship between water retrieval time and
TF remained significant when considered in multivari-
ate analysis alongside the other risk factor covariates
mentioned in the above paragraph (OR 0.50, 95% CI
0.4–0.7, p < 0.001). As in the univariate analysis, none
of the other risk factors showed relationships to TF
prevalence, though the low prevalence of TF detected
in this survey makes the analysis of risk factors more
difficult.
When analyses included TF in all age groups,
similar results were found, showing a significant,
negative relationship between a round-trip of less
than 30 minutes to collect water for face washing
and TF prevalence (OR 0.53, 95% CI 0.4–0.7,
p < 0.001). No other investigated risk factor was
found to have a significant relationship with TF.
Discussion
Obtaining prevalence data at the district level is a pre-
requisite for planning and implementing coherent and
efficient interventions for trachoma elimination. The
present study, which used methods recommended by
WHO for sampling of populations and examination for
trachoma, was designed to determine trachoma preva-
lence in 17 districts in Senegal which had had no prior
district-level trachoma surveys.
Table 3. Prevalence of trachomatous inflammation–follicular (TF) and trichiasis by district, Senegal, 2014.
Region District
No of children (1–9 years)
examined
TF % (95%
CI)
No of adults (≥15 years)
examined
Trichiasis % (95% CI) [population
≥15 years]
Kolda Kolda 1639 3.8 (1.7–6.1) 1876 0.6 (0.3–1.0)
Médina Yoro
Foulah
1636 3.6 (2.0–5.0) 1763 0.2 (0.1–0.4)
Vélingara 1445 4.0 (2.2–6.0) 1737 0.4 (0.1–0.8)
Matam Kanel 1477 2.1 (1.2–3.1) 1516 0.1 (0.0–0.3)
Matam 1507 3.6 (2.2–5.0) 1740 0.0 (0.0–0.0)
Ranérou 1576 1.9 (1.1–2.8) 1392 0.0 (0.0–0.1)
Thilogne 1402 3.6 (2.2–5.1) 1907 0.1 (0.0–0.2)
Saint-Louis Dagana 1358 1.9 (0.9–3.0) 1799 0.1 (0.0–0.1)
Pété 1579 1.9 (1.0–3.1) 1834 0.0 (0.0–0.0)
Podor 1531 1.7 (1.0–2.6) 1944 0.1 (0.0–0.1)
Richard Toll 1393 3.7 (2.3–5.1) 1831 0.1 (0.0–0.2)
Saint-Louis 1352 5.1 (3.2–7.5) 1766 0.4 (0.1–0.6)
Sédhiou Bounkiling 1579 2.5 (1.1–4.2) 1675 0.7 (0.4–1.1)
Goudomp 1660 2.7 (1.7–3.8) 1729 1.0 (0.6–1.4)
Sédhiou 1628 1.8 (1.0–2.9) 1767 1.1 (0.7–1.5)
Ziguinchor Oussouye 1137 1.4 (0.6–2.0) 1997 0.2 (0.1–0.3)
Ziguinchor 1245 3.0 (1.8–4.3) 2072 0.6 (0.2–1.0)
Figure 3. Prevalence of trachomatous inflammation–follicular (TF) in the 17 districts mapped for trachoma, Senegal, 2014.
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Active trachoma
Based on TF prevalence estimates, implementation
of the full SAFE strategy is not warranted in 16 of
the 17 districts surveyed. In Saint Louis district,
which registered a TF prevalence of 5.1%, a one-
year implementation of the SAFE strategy’s A, F,
and E components, followed by an impact survey,
could be considered.24 These prevalences, which are
generally lower than those for other districts of
Senegal presented in Table 1, are in line with
expectations of risk based on the earlier region-
level prevalence surveys.
Trichiasis
According to WHO guidelines, TT prevalence ≥0.2% in
persons aged 15 years or above constitutes a public health
problem: the TT threshold for elimination is a TT preva-
lence of <1 case per 1,000 total population, with an assump-
tion that 50% of the population is aged 15 years or
above.25,26 Our results show that trichiasis is a public health
problem in 9 of the sampled districts (i.e., Kolda, Médina
Yoro Foulah, Vélingara, Saint Louis, Bounkiling,
Goudomp, Sédhiou, Oussouye, and Ziguinchor); conse-
quently, increased provision of surgical interventions for
trichiasis is required in these districts. The prevalences
Figure 4. Prevalence of trichiasis in the 17 districts mapped for trachoma, Senegal, 2014.
Figure 5. Trachomatous inflammation–follicular (TF) prevalence by age amongst children aged 1–9 years across 17 surveyed
districts, Senegal, 2014. Whiskers indicate 95% confidence intervals.
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recorded are generally lower than those presented in
Table 1, a result which is in line with expectations of risk
based on the earlier region-level prevalence surveys. The
inability to distinguish between TT and trichiasis not
caused by trachoma was a limitation to our surveys; it is
possible that the actual prevalence of TT was lower than
surveyed.
The observation, in certain districts, of a high trichiasis
prevalence and low TF prevalence likely reflects higher
endemicity of active trachoma several decades prior to
these surveys. If active trachoma has since become rare,
this is likely due to improvement in living conditions, as
evidenced by the relatively good access to water and avail-
ability of latrines that we demonstrated (Table 2). The
finding that trichiasis prevalence was higher among
females than males adds weight to the observation made
in other contexts that women are more likely to have
trichiasis than men, perhaps as a result of their increased
contact with young children.18 However, with nearly 17%
(5,417/32,392) of adult males absent compared to 5.8% of
adult females (2,257/39,101), caution must be applied, as
these absences among males could bias upward the esti-
mated prevalence of trichiasis overall. Our process of age-
and gender-standardization of trichiasis prevalence esti-
mates will have partially counterbalanced this potential
bias, but it is not possible to estimate the residual magni-
tude of the effect.
There are approximately 120–130 TSOs in Senegal,
and all of them are trained to perform trichiasis surgery.
The quality of surgery delivered depends largely on how
frequently the TSOs have the opportunity to practice this
skill – which, in turn, depends partly on patients’ access
to and demand for surgery. To increase access, the
MSAS has tried different strategies, such as offering
surgery free of charge (with the service paid for by a
partner organization). More aggressive strategies may be
warranted to increase demand for surgery, particularly
among people who may currently be practicing epilation
as an alternative to surgery. One such strategy is known
locally as “commando,” whereby TSOs rotate through
and focus on performing surgeries in different regions of
the country over the course of the year. This strategy
would have the added advantage of giving the selected
TSOs the opportunity to conduct the procedure more
frequently, thereby improving their surgical skills which
would help to increase demand for the service. Such a
strategy will not be optimal after elimination as a public
health problem, when services will need to be integrated
into usual health care delivery platforms. Strengthening
of the health care system is vital to ensure that this
process is not followed by complete loss of capacity to
detect trichiasis and deliver trichiasis surgery.
Risk factors
We examined selected potential risk factors for tra-
choma. The most obvious finding to emerge from our
analysis was a significant negative correlation between
having active trachoma and requiring less than 30 min-
utes to retrieve water for face washing. It has been
argued that better access to water may reduce the
transmission of C. trachomatis infection.3 However,
previous studies evaluating the association between
increased distance to water and prevalence of active
disease have delivered inconsistent results.27–35
Others have suggested that the quantity of water
brought into the household might be more important
than the distance.36 Bailey et al., working in The
Gambia, found that after controlling for distance to
water and other factors, families with trachoma used less
Figure 6. Trichiasis prevalence by age amongst individuals aged ≥15 years across 17 surveyed districts, Senegal, 2014. Whiskers
indicate 95% confidence intervals.
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water for washing children than those without trachoma,
irrespective of the amount of available water in the
household.37 In the current study, the quantity of water
brought was not measured and use of water was not
observed, but a round trip of less than 30 minutes to
collect water was associated with lower TF prevalence. It
would be of interest to study facial cleanliness as a follow-
up. Unlike previous studies,34,35,38,39 we did not find an
association between TF prevalence and reported use of
unimproved sanitation by household adults.
Implications for program planning
For the districts surveyed here, the main priorities
should be implementation of the S component of
SAFE in the nine districts with trichiasis prevalences
≥0.2% in adults aged 15 years and above, to prevent
worsening of vision in those who are already going
blind from trachoma; and a one-year implementation
of the SAFE strategy’s A, F, and E components in the
single district with TF prevalence 5.1% in children aged
1–9 years, followed by an impact survey. MDA in this
district is scheduled for 2017.
In 2015, the International Trachoma Initiative,
which supplies donated azithromycin (Zithromax®,
Pfizer) for MDA against trachoma, notified national
programs that it would welcome azithromycin applica-
tions for districts with baseline TF prevalence of
5–9.9% among children aged 1–9 years, to be distrib-
uted alongside F and E interventions, in an effort to
ensure that all districts achieve TF prevalences below
5%.24 A total of nine districts which have not yet
initiated MDA for trachoma fall into this category. Of
these, one district completed mapping in 2004, three in
2005, one in 2010, two in 2011, one in 2013, and one
(which will conduct MDA in 2017, as noted above) as
part of the 2014 round of surveys reported here. In
collaboration with its partners, Senegal’s MSAS is res-
urveying the eight districts in this category that con-
ducted mapping prior to 2014, and will determine
appropriate strategies based on the findings.
Acknowledgments
We gratefully thank the populations and leadership of the
communities where the surveys were conducted. These sur-
veys would not have been possible without the field workers,
the health post head nurses and the health district head
doctors who facilitated the work with the communities. We
also thank John Kraemer of Georgetown University for his
assistance in analyzing the survey data, and Rebecca M.
Flueckiger, Alexandre Pavluck, and Brian K. Chu of the
Task Force for Global Health for their work on the GTMP.
Declaration of interest
None of the authors have any proprietary interests or con-
flicts of interest related to this submission.
Funding
These surveys and preparation of this manuscript were made
possible thanks to funding from the United States Agency for
International Development (USAID) and the ENVISION
project, led by RTI International under cooperative agree-
ment number AID-OAA-A-11-00048. Core support to the
Global Trachoma Mapping Project (GTMP) was provided by
a grant from the United Kingdom’s Department for
International Development (DFID) (ARIES: 203145) to
Sightsavers. A committee established in March 2012 to exam-
ine issues surrounding completion of global trachoma map-
ping was initially supported by a grant from Pfizer to the
International Trachoma Initiative. LN was a consultant for
RTI International under the ENVISION project. AWS was a
Wellcome Trust Intermediate Clinical Fellow (098521) at the
London School of Hygiene & Tropical Medicine. None of the
funders had any role in project design, in project implemen-
tation or analysis or interpretation of data, in the decisions
on where, how or when to publish in the peer reviewed press,
or in preparation of this manuscript. The authors’ views
expressed in this publication do not necessarily reflect the
views of USAID or the US or UK Governments.
References
1. Baneke A. Review: targeting trachoma: strategies to
reduce the leading infectious cause of blindness.
Travel Med Infect Dis. 2012;10(2):92–96. doi:10.1016/j.
tmaid.2012.01.005.
2. Solomon AW, Holland MJ, Burton MJ, et al. Strategies
for control of trachoma: observational study with
quantitative PCR. Lancet. 2003;362(9379):198–
204. doi:10.1016/S0140-6736(03)13909-8.
3. Hu VH, Harding-Esch EM, Burton MJ, Bailey RL,
Kadimpeul J, Mabey DCW. Epidemiology and control of
trachoma: systematic review. Trop Med Int Heal. 2010;15
(6):673–691. doi:10.1111/j.1365-3156.2010.02521.x.
4. Taylor HR, Burton MJ, Haddad D, West S, Wright H.
Trachoma. Lancet. doi:10.1016/S0140-6736(13)62182-0.
5. Bourne RRA, Stevens GA, White RA, et al. Causes of
vision loss worldwide, 1990–2010: A systematic analy-
sis. Lancet Glob Health. 2013;1(6):339–349.
doi:10.1016/S2214-109X(13)70113-X.
6. World Health Organization Alliance for the Global
Elimination of Trachoma by 2020. Eliminating
Trachoma: Accelerating Towards 2020. London:
International Coalition for Trachoma Control. 2016.
7. World Health Organization. Validation of Elimination
of Trachoma as a Public Health Problem (WHO/HTM/
NTD/2016.8). Geneva: World Health Organization
2016.
8. Ministère de la Santé Publique et de l’Action Sociale.
Programme National De Lutte Contre La Cécité. Plan
d’Action 1998-2007. Dakar: Ministère de la Santé
Publique et de l'Action Sociale. 1997.
50 B. SARR ET AL.
9. Ministère de la Santé de l’Hygiène Publique et de la
Prévention. Plan Directeur De Lutte Intégrée Contre Les
Maladies Tropicales Négligées. Dakar: Ministère de la
Santé, de l'Hygiène Publique et de la Prévention;
2011–2015. 2011.
10. Saal MB, Schemann JF, Saar B, et al. Trachoma in
Senegal: results of a national survey. Médecine Trop.
2003;63(1):53–59.
11. République du Sénégal. Décret N° 2008-1025 Du 10
Septembre 2008. Senegal: Journal Officiel N° 6446 du
mercredi 31 décembre 2008 N - S; 2008. http://www.jo.
gouv.sn/spip.php?article7213.
12. Harding-Esch EM, Kadimpeul J, Sarr B, et al.
Population-based prevalence survey of follicular
trachoma and trachomatous trichiasis in the
Casamance region of Senegal. BMC Public Health.
2018;18(1):62. doi:10.1186/s12889-017-4605-0.
13. Solomon AW, Zondervan M, Kuper H, Buchan J,
Mabey DCW, Foster A. Trachoma Control: A Guide
for Programme Managers. Geneva: World Health
Organization. 2006.
14. Sarr B, Sissoko M, Fall M, Cohn D, Solomon AW,
Bailey RL. Segmented mapping of trachoma in Touba
District, Senegal. In: Trachoma Scientific Informal
Workshop. Geneva; 2017.
15. Solomon AW, Pavluck AL, Courtright P, et al. The
global trachoma mapping project: methodology of a
34-country population-based study. Ophthalmic
Epidemiol. 2015;22(3):214–225. doi:10.3109/
09286586.2015.1037401.
16. Thylefors B, Dawson CR, Jones BR, West SK, Taylor
HR. A simple system for the assessment of trachoma
and its complications. Bull World Health Organ.
1987;65(4):477–483.
17. Courtright P, Gass K, Lewallen S, et al. Global Trachoma
Mapping Project: Training for Mapping of Trachoma
(Version 2). London: International Coalition for
Trachoma Control; 2013. http://www.trachomacoalition.
org/node/357.
18. Cromwell EA, Courtright P, King JD, Rotondo LA,
Ngondi J, Emerson PM. The excess burden of trachoma-
tous trichiasis in women: a systematic review and meta-
analysis. Trans R Soc Trop Med Hyg. 2009;103(10):985–
992. doi:10.1016/j.trstmh.2009.03.012.
19. Pavluck A, Chu B, Mann Flueckiger R, Ottesen E.
Electronic data capture tools for global health pro-
grams: evolution of LINKS, an Android-, Web-Based
System. PLoS Negl Trop Dis. 2014;8(4):1–19.
doi:10.1371/journal.pntd.0002654.
20. Agence Nationale de la Statistique et de la
Démographie. Recensement Général de La Population
et de l’Habitat, de l’Agriculture et de l’Elevage
(RGPHAE) 2013. Rapport Provisoire; 2014.
21. World Health Organization Strategic and Technical
Advisory Group on Neglected Tropical Diseases.
Technical Consultation on Trachoma Surveillance.
September 11−12, 2014, Task Force for Global Health,
Decatur, USA (WHO/HTM/NTD/2015.02). Geneva:
World Health Organization. 2015.
22. World Health Organization Alliance for the Global
Elimination of Trachoma by 2020. Second Global
Scientific Meeting on Trachomatous Trichiasis. Cape
Town, 4-6 November 2015 (WHO/HTM/NTD/
2016.5).. Geneva: World Health Organization. 2016.
23. http://www.wssinfo.org/definitions-methods/watsan-
categories/(accessed 4 Nov 2016).
24. International Trachoma Initiative. Diagram on
Decision Making for Antibiotic Treatment of
Trachoma, version 9.
25. World Health Organization. Report of the 2nd Global
Scientific Meeting on Trachoma, Geneva, 25-27 August,
2003. Geneva: World Health Organization. 2003.
26. World Health Organization. Report of the 3rd Global
Scientific Meeting on Trachoma, Johns Hopkins
University, Baltimore, MD, 19-20 July 2010. Geneva:
World Health Organization. 2010.
27. West S, Lynch M, Turner V, et al. Water availability and
trachoma. Bull World Health Organ. 1989;67(1):71–75.
28. Taylor HR, West SK, Mmbaga BB, et al. Hygiene
factors and increased risk of trachoma in central
Tanzania. Arch Ophthalmol. 1989;107(12):1821–1825.
doi:10.1001/archopht.1989.01070020903037.
29. Zerihun N. Trachoma in Jimma zone, south western
Ethiopia. Trop Med Int Health. 1997;2(12):1115–1121.
30. J-F S, Sacko D, Malvy D, et al. Risk factors for tra-
choma in Mali. Int J Epidemiol. 2002;31(1):194–201.
31. Kuper H, Solomon AW, Buchan J, Zondervan M, Foster
A,Mabey D. A critical review of the SAFE strategy for the
prevention of blinding trachoma. Lancet Infect Dis.
2003;3(6):372–381. doi:10.1016/S1473-3099(03)00659-5.
32. Stocks ME, Ogden S, Haddad D, Addiss DG, McGuire
C, Freeman MC. Effect of water, sanitation, and
hygiene on the prevention of trachoma: a systematic
review and meta-analysis. PLoS Med. 2014;11(2):
e1001605. doi:10.1371/journal.pmed.1001605.
33. Bero B, Macleod C, Alemayehu W, et al. Prevalence of
and risk factors for trachoma in Oromia Regional State
of Ethiopia: results of 79 population-based prevalence
surveys conducted with the Global Trachoma Mapping
Project. Ophthalmic Epidemiol. 2016;23(6):392–405.
doi:10.1080/09286586.2016.1243717.
34. Elshafie BE, Osman KH, Macleod C, et al. The epide-
miology of trachoma in Darfur States and Khartoum
State, Sudan: results of 32 population-based prevalence
surveys. Ophthalmic Epidemiol. 2016;23(6):381–391.
doi:10.1080/09286586.2016.1243718.
35. Adera TH, Macleod C, Endriyas M, et al. Prevalence of
and risk factors for trachoma in Southern Nations,
Nationalities, and Peoples’ Region, Ethiopia: results of
40 population-based prevalence surveys carried out
with the Global Trachoma Mapping Project.
Ophthalmic Epidemiol. 2016;23(sup1). doi:10.1080/
09286586.2016.1247876.
36. Kupka K, Nizetic B, Reinhards J. Sampling studies on the
epidemiology and control of trachoma in southern
Morocco. Bull World Health Organ. 1968;39(4):547–566.
37. Bailey R, Downes B, Downes R, Mabey D. Trachoma
and water use; a case control study in a Gambian
village. Trans R Soc Trop Med Hyg. 1991;85(6):824–
828. doi:10.1016/0035-9203(91)90470-J.
38. Ko R, Macleod C, Pahau D, et al. Population-based
trachoma mapping in six evaluation units of Papua
New Guinea. Ophthalmic Epidemiol. 2016;23
(sup1):22–31. doi:10.1080/09286586.2016.1235715.
OPHTHALMIC EPIDEMIOLOGY 51
39. Mpyet C, Muhammad N, AdamuMD, et al. Prevalence of
trachoma in Kano State, Nigeria: results of 44 district local
government area-level surveys. Ophthalmic Epidemiol.
2017;24(3):195–203. doi:10.1080/09286586.2016.1265657.
Appendix
The Global Trachoma Mapping Project Investigators are:
Agatha Aboe (1,11), Liknaw Adamu (4), Wondu
Alemayehu (4,5), Menbere Alemu (4), Neal D. E. Alexander
(9), Berhanu Bero (4), Simon J. Brooker (1,6), Simon Bush
(7,8), Brian K. Chu (2,9), Paul Courtright (1,3,4,7,11),
Michael Dejene (3), Paul M. Emerson (1,6,7), Rebecca M.
Flueckiger (2), Allen Foster (1,7), Solomon Gadisa (4),
Katherine Gass (6,9), Teshome Gebre (4), Zelalem Habtamu
(4), Danny Haddad (1,6,7,8), Erik Harvey (1,6,10), Dominic
Haslam (8), Khumbo Kalua (5), Amir B. Kello (4,5), Jonathan
D. King (6,10,11), Richard Le Mesurier (4,7), Susan Lewallen
(4,11), Thomas M. Lietman (10), Chad MacArthur (6,11),
Colin Macleod (3,9), Silvio P. Mariotti (7,11), Anna Massey
(8), Els Mathieu (6,11), Siobhain McCullagh (8), Addis
Mekasha (4), Tom Millar (4,8), Caleb Mpyet (3,5), Beatriz
Muñoz (6,9), Jeremiah Ngondi (1,3,6,11), Stephanie Ogden
(6), Alex Pavluck (2,4,10), Joseph Pearce (10), Serge Resnikoff
(1), Virginia Sarah (4), Boubacar Sarr (5), Alemayehu Sisay
(4), Jennifer L. Smith (11), Anthony W. Solomon
(1,2,3,4,5,6,7,8,9,10,11), Jo Thomson (4), Sheila K. West
(1,10,11), Rebecca Willis (2,9).
Key: (1) Advisory Committee, (2) Information
Technology, Geographical Information Systems, and
Data Processing, (3) Epidemiological Support, (4)
Ethiopia Pilot Team, (5) Master Grader Trainers, (6)
Methodologies Working Group, (7) Prioritisation
Working Group, (8) Proposal Development, Finances
and Logistics, (9) Statistics and Data Analysis, (10)
Tools Working Group, (11) Training Working Group.
52 B. SARR ET AL.
